COVAXIN to begin Clinical trial for age Group of 2 to 18 Years, DGCI gives nod

NEW DELHI: On Thursday, the Drugs Controller General of India (DCGI), the National Regulator of the…

DCGI approves anti-Covid drugsd developed by DRDO

NEW DELHI: On Saturday, the Drugs Controller General of India (DCGI) has given its nod to…